Profil
Nedira Salzman-Frenkel is currently Vice President-Business Development at BioHarvest Sciences, Inc. since 2026.
Formerly, served as Vice President-Business Development at Neurosense Therapeutics Ltd. from 2022 to 2025 and Chief Executive Officer at Salzman Group, Inc. from 2017 to 2021.
Education includes an MBA from Tel-Aviv University, graduate studies at The Hebrew University of Jerusalem, and undergraduate studies at Ben-Gurion University of the Negev.
Postes actifs de Nedira Salzman-Frenkel
| Sociétés | Poste | Début |
|---|---|---|
| BIOHARVEST SCIENCES INC. | Corporate Officer/Principal | 13/05/2026 |
Anciens postes connus de Nedira Salzman-Frenkel
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Corporate Officer/Principal | 01/06/2025 |
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative pharmaceuticals of bifunctional edox-based small molecules | Directeur Général | 01/10/2021 |
Formation de Nedira Salzman-Frenkel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative pharmaceuticals of bifunctional edox-based small molecules | Commercial Services |
BioHarvest Sciences, Inc.
BioHarvest Sciences, Inc. Agricultural Commodities/MillingProcess Industries Develops bio-cell growth platform technology | Process Industries |
Neurosense Therapeutics Ltd.
Neurosense Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage drug development company | Health Technology |
















